$2.55
+0.13 (+5.37%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+110.6% upside
Low Target
$3.28
Average Target
$5.37
High Target
$6.50
Current Price
$2.55
Current
$2.55
$2.55
Target
$5.37
$5.37
$3.28
$5.37 avg
$6.50
Scenario Analysis
Bear Case
$3.28
28.6%
Low target
Base Case
$5.37
+110.6%
Avg target
Bull Case
$6.50
+154.9%
High target
Risk/Reward
5.4x
Highly favorable
Price in Context
52-Week High
$8.54
-70.1% from high
52-Week Low
$1.99
+28.3% from low
Target vs 52W High
$5.37
-37.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.9% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +157.7% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.5% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.0% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -12.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.5% |